Daiichi Sankyo
Search results
Jul 11, 2024 · Latest findings from Eisai’s robust Alzheimer’s disease (AD) pipeline will be shared, including the importance of continued treatment of AD, which is a progressive neurodegenerative disease that begins before plaque deposition and continues after plaque removal
Eisai India. At Eisai Pharmaceuticals India Pvt. Ltd., we dedicate our work to realize Eisai's corporate concept of hhc (human health care). We are committed to increasing benefits to patients and the people in the daily living domain.
Jul 12, 2024 · Eisai is a research-based human health care company that discovers, develops and markets phamaceutical products internationally. Learn more about Eisai today.
Access timely educational, scientific, and clinical information, as well as resources about Eisai FDA-approved products and investigational agents for health care professionals. Eisai investigates challenging disease states in oncology and neurology by prioritizing our human health care mission.
We are a global leading research-based pharmaceutical company with operations in Asia, Australia, Europe, the Middle East, Latin America, New Zealand and the United States. FIND OUT MORE
At Eisai India caring for people is our work. Satisfying unmet medical needs and increasing benefits to patients, their families, and caregivers is Eisai’s Human health care (hhc) mission.
Jul 16, 2024 · In Japan, Seren Pharma (Headquarters: Tokyo) and Sato Pharma have developed fosravuconazole based on the exclusive rights to develop, commercialize, and sublicense granted by Eisai. The treatment has been marketed by Sato Pharma as the oral antifungal agent Nailin ® for the indication of “onychomycosis” since July 2018, which Eisai is co-promoting.
Feb 5, 2023 · AmbitionBox has 282 Eisai Pharmaceuticals reviews submitted by Eisai Pharmaceuticals employees. Read reviews on salaries, working hours, work culture, office environment, and more to know if Eisai Pharmaceuticals is the right company for you.
Eisai Pharmaceuticals India Pvt. Ltd.(Formerly Eisai Pharmatechnology and Manufacturing Pvt. Ltd.
Eisai (pronounced 'ā-zī’) is derived from the Japanese word for 'health product' and, here at Eisai, we discover, develop and market innovative, high quality medicines throughout the world. Working across the spectrum of pharmaceuticals and consumer health, chemicals and food additives, production systems and equipment, we are a human healthcare company that actively participates with, and contributes to, any healthcare system. We place primary emphasis on patients and their families ...
